The first step in utilizing immune-modulating therapies: immune status determination

Area of Science:

• Immunology
• Critical Care Medicine
• Flow Cytometry

Background:

• Assessing immune status is crucial for managing inflammatory diseases.
• Pancreatitis involves complex immune dysregulation.
• Current methods for immune status assessment can be time-consuming.

Purpose of the Study:

• To evaluate phospho-specific whole blood flow cytometry for assessing activated signaling pathways in leukocytes from pancreatitis patients.
• To determine if this method can provide insights into a patient's current immune state.

Main Methods:

• Single center study utilizing phospho-specific whole blood flow cytometry.
• Isolation of leukocytes from pancreatitis patients.
• Analysis of activated signaling pathways in immune cells.

Main Results:

• Phospho-specific flow cytometry successfully assessed activated signaling pathways in leukocytes.
• The methodology showed potential for determining the immune status of pancreatitis patients.
• Despite a clinically homogeneous cohort, heterogeneous data were observed, indicating individual immune variations.

Conclusions:

• Determining immune status prior to immune-modulatory therapy is beneficial in inflammatory diseases.
• Rapid whole blood phospho-specific flow cytometry offers potential for improved early diagnosis.
• This technique may provide a rational basis for personalized immunomodulatory therapies.